Advertise on podcast: Decera Clinical Education Medical Specialties Podcast

In this episode, 2 experts discuss the evolving role of weekly insulin therapy in modern type 2 diabetes (T2D) management. They share practical considerations for initiating or switching to these novel agents, including how to accurately convert daily doses, follow titration schedules, and support adherence and patient preferences through shared decision-making. Learn how you can ensure optimized glycemic control and reduced treatment burden in your patients with T2D by integrating weekly insulin therapies in your endocrinology, diabetology, or primary care practice. Presenters Richard E. Pratley, MD Samuel E. Crockett Chair in Diabetes Research Medical Director, AdventHealth Diabetes Institute Senior Investigator and Diabetes Program Lead AdventHealth Translational Research Institute Adjunct Professor of Medicine Johns Hopkins University School of Medicine Orlando, Florida Jay H. Shubrook, DO, FAAFP, FACOFP Professor, Diabetologist Department of Clinical Sciences and Community Medicine Touro University California, College of Osteopathic Medicine Vallejo, California Link to full program: https://bit.ly/4wyjOg7 Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Two experts in obesity medicine discuss the latest advances in obesity care, including: Current data for incretin-based therapiesBeyond the scale—individualizing OMM selection based on weight-related comorbidities and cardiometabolic riskCommon contraindications and warnings associated with certain OMMsShared decision-making strategies to inform treatment selection.PresentersAmy Butts, PA-C, DFAAPA, BC-ADM, CDCESEndocrine Physician AssociateWVU Medicine Wheeling HospitalImmediate Past President of American Society of Endocrine Physician AssociatesWellsburg, West Virginia Nicholas Pennings, DOProfessor of Family MedicineCampbell University School of Osteopathic MedicineDirector of Clinical EducationObesity Medicine AssociationBuies Creek, North Carolina Link to full program:https://bit.ly/4v7eIY4 Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Four inflammatory bowel disease (IBD) experts explore case-based strategies for optimizing advanced IBD therapy and long-term disease management early in real-world practice. They discuss practical approaches for implementing treat-to-target via strategic treatment sequencing, therapeutic drug monitoring, and maintenance approaches while supporting individualized, evidence-based care for patients with IBD. Presenters Jessica R. Allegretti, MD, MPH, FACG, AGAF Medical Director, Infusion Services Director, Crohn’s and Colitis Center Director of Clinical Research Director, Fecal Microbiota Transplant Program Division of Gastroenterology, Hepatology and Endoscopy Brigham and Women’s Hospital Associate Professor of Medicine, Harvard Medical School Boston, Massachusetts Jordan E. Axelrad, MD, MPH, AGAF, FACG, FCCF Co-Director, Inflammatory Bowel Disease Center at NYU Langone Health Associate Professor of Medicine Division of Gastroenterology and Hepatology NYU Grossman School of Medicine New York, New York Russell D. Cohen, MD, FACG, AGAF Professor of Medicine, Pritzker School of Medicine Co-Director, Digestive Diseases Center Clinical Director, Inflammatory Bowel Disease Center Co-Director, Advanced IBD Fellowship Program The University of Chicago Medicine Chicago, Illinois Amy Stewart, MSN, FNP-C Lead Advanced Practice Provider Capital Digestive Care Washington, DC Link to full program: https://bit.ly/4wvm7l4 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

As current understandings of obesity (ie, a chronic disease requiring long-term management) are adopted across the world, screening and treatment can no longer follow a one-size-fits-all approach. Listen in as 3 global experts in obesity medicine highlight the emerging evidence from recent conferences that are changing real-world practice today. Learn how the latest findings apply to specific patient populations across the United States, Europe, and Asia as well as why healthcare professionals should individualize treatment based on patient preferences and relevant risk factors. Presenters: Stephano Del Prato, MD Professor Emeritus of Endocrinology University of Pisa Pisa, Italy Soo Lim, MD, PhD Professor of Medicine Department of Internal Medicine Seoul National University College of Medicine and Seoul National University Bundang Hospital Seoul, South Korea Donna H. Ryan, MD Professor Emerita Pennington Biomedical Research Center Louisiana State University New Orleans, Louisiana Link to full program:https://bit.ly/4pwFhEo Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast, Jennifer Green, MD, and Jay H. Shubrook, DO, FAAFP, FACOFP, share strategies for integrating incretin-based therapies in type 2 diabetes (T2D) management in the primary care setting, including: Importance of moving beyond a glucose-centric approach to T2D care  Current evidence for incretin-based therapies in T2D Rationale for integrating these therapies into the primary care setting Shared decision-making strategies to discuss optimal T2D treatment options with patients Timing for endocrinology referral Presenters: Jennifer Green, MD Professor of Medicine Division of Endocrinology Duke Clinical Research Institute Duke University School of Medicine Durham, North Carolina Jay H. Shubrook, DO, FAAFP, FACOFP Professor, Diabetologist Department of Clinical Sciences and Community Medicine Touro University California, College of Osteopathic Medicine Vallejo, California Full program link: https://bit.ly/4uSKCqv Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Nancy Reau, MD, reviews key highlights of the most impactful primary biliary cholangitis (PBC) research and gain insights on how to apply these new advances to clinical practice.  Topics covered include: Treatment GoalsLong-term Data With PPAR AgonistsInvestigational Therapies for PruritusPresenter:  Nancy Reau, MD Professor of Medicine Richard B. Capps Chair of Hepatology Chief, Section of Hepatology Associate Director, Solid Organ Transplantation Rush University Medical Center Chicago, Illinois To download the accompanying slides, visit the program page for this episode:  https://bit.ly/4b2d6YD   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Jay H. Shubrook, DO, FACOFP, FAAFP, and Chrisopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA, discuss the latest advances in caring for patients with overweight or obesity in the primary care setting, including: The Lancet Commission’s new obesity definitions and diagnostic criteriaKey data on incretin-based antiobesity medications like semaglutide and tirzepatideBest practices for patient discussionsStrategies for incorporating new evidence in your primary care practicePresenters Jay H. Shubrook, DO, FACOFP, FAAFP Professor and Diabetologist Department of Clinical Sciences and Community Health Touro University California College of Osteopathic Medicine Vallejo, California Christopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA Bariatric Services Medical Director, Ascension Wisconsin Obesity Medicine Director, Ascension Columbia St Mary’s Bariatric Center Trustee, Obesity Medicine Association Adjunct Assistant Professor of Pediatrics Medical College of Wisconsin Milwaukee, Wisconsin Link to full program: https://bit.ly/4rG7QQp Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Historically, key symptoms of primary biliary cholangitis (PBC), such as pruritus and fatigue, have been understudied and undertreated. Listen now to learn how symptom management should be considered independently of PBC management, and how new therapeutic agents can help. Topics covered include: Mechanisms of pruritus and fatigue in PBCNonpharmacologic treatment optionsAn overview of clinical trial data supporting second-line agents for symptom management:BezafibrateElafibranorSeladelparInvestigational agents:VolixibatLinerixibatSetanaxibThis episode is the third of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/44ZJ5os Presenters: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Aparna Goel, MD Clinical Associate Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Aliya F. Gulamhusein, MD,  MPH, FRCPC Professorship in PSC Research Clinician Investigator, Toronto General Hospital Assistant Professor, University of Toronto Division of Gastroenterology and Hepatology University Health Network Toronto, Canada Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

New therapeutic agents for second-line treatment are raising the bar for primary biliary cholangitis (PBC) management. Listen now to learn how to incorporate these new agents into clinical practice and how these agents will impact attainment of treatment goals. Topics covered include: Available agents for second-line treatment of PBC An overview of clinical trial data supporting second-line agents:Obeticholic acid (OCA)BezafibrateElafibranorSeladelparThis episode is the second of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/48MEc3r Presenters: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Aparna Goel, MD Clinical Associate Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Aliya F. Gulamhusein, MD, MPH, FRCPC Professorship in PSC Research Clinician Investigator, Toronto General Hospital Assistant Professor, University of Toronto Division of Gastroenterology and Hepatology University Health Network Toronto, Canada Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Advancements in our understanding of primary biliary cholangitis (PBC) and new therapeutic agents have reshaped the care landscape of PBC. Listen now to learn how these developments are helping to redefine and elevate treatment goals. Topics covered include: How and when to assess treatment responseRisk factors in PBCBiochemical treatment response and fibrosis stage as predictors of transplant-free survivalDynamics of liver stiffness measurements and clinical outcomes in PBC The importance of bilirubin and alkaline phosphatase normalizationThis episode is the first of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/44ZJ5os Presenters: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Aparna Goel, MD Clinical Associate Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Aliya F. Gulamhusein, MD, MPH, FRCPC Professorship in PSC Research Clinician Investigator, Toronto General Hospital Assistant Professor, University of Toronto Division of Gastroenterology and Hepatology University Health Network Toronto, Canada Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join expert faculty, Dr Alan Bonder and Dr Stuart Gordon, to learn more about key gaps in PBC management and how these shortfalls can be addressed through identification of appropriate biochemical goals, proper assessment and management of PBC symptoms, and current second-line therapies.  Presenters: Alan Bonder, MD, AGAF Associate Professor of Medicine Medical Director of Liver Transplant Beth Israel Deaconess Medical Center Department of Gastroenterology Harvard Medical School Boston, Massachusetts Stuart C. Gordon, MD, FAASLD Professor of Medicine Wayne State University School of Medicine Professor of Medicine Michigan State University College of Medicine Henry Ford Health Detroit, Michigan Link to full program: https://bit.ly/3M29pI1 Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Tune in to learn from patient advocate, Maria G. Morais, RN, how you can integrate patient insights and priorities into treatment plans for PBC. Topics covered include: The Canadian PBC Society Survey: Comorbidities and Treatment GoalsDefining and Achieving Goal-Driven Care for PBCRecent Advances in PBC ManagementNewer Agents for Second-line Treatment of PBCPresenters: Maria G. Morais, RN PBC Transplant Patient VP Patient Advocacy Canadian PBC Society Toronto, Canada Link to full program: https://bit.ly/44ySoL3 Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice. Topics covered include:  Methods of Assessing PBC Disease ProgressionNewer Agents for Second-line Treatment of PBCPrioritizing Symptom Management and Quality of Life With PBC TreatmentPresenters: Christopher L. Bowlus, MD Lena Valenta Professor and Chief Division of Gastroenterology and Hepatology School of Medicine  University of California Davis  Sacramento, California Sonal Kumar, MD, MPH Assistant Professor of Medicine Division of Gastroenterology and Hepatology Weill Cornell Medical College New York, New York Link to full program:  https://bit.ly/43nHx6U Get access to all of our new podcasts by subscribing to the CCO Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.       Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen as pulmonologist Peter Dicpinigaitis discusses his approach to the diagnosis and management of patients with refractory chronic cough in the context of a clinically relevant case and provides insights regarding emerging therapies. Presenter Peter Dicpinigaitis, MD Professor of Medicine Albert Einstein College of Medicine Division of Critical Care Medicine Montefiore Medical Center Director, Montefiore Cough Center Bronx, New York Link to full program: https://bit.ly/4kweynG Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen as Michael S. Benninger, MD, describes his approach to the diagnosis and management of chronic cough and refractory chronic cough in the context of a clinically relevant case. Presenter Michael S. Benninger, MD Professor of Otolaryngology-Head and Neck Surgery Lerner College of Medicine The Cleveland Clinic President, International Association of Phonosurgery Cleveland, Ohio Link to full program: https://bit.ly/4kweynG Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.